Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

Collaborative Group on Epidemiological Studies of Ovarian Cancer

Read Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies by Collaborative Group on Epidemiological Studies of Ovarian Cancer in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4427760.txt.

Description

Menopausal hormone therapy and ovarian cancer risk were pooled by the Collaborative Group on Epidemiological Studies of Ovarian Cancer in The Lancet, using records from fifty-two separate studies. Half of the studies with data on this question had never been published. Some older designs risked bias from who took part or what women recalled. So the group reanalyzed each person's data in one center.

In the forward-looking studies, women who were current users of hormone therapy had a raised risk of ovarian cancer, even with less than five years of use. Risk was alike in European and American studies and for estrogen-only and combined estrogen-progestagen products. Including women who had stopped within the past five years gave a similar picture. The work gives a careful, bias-checked estimate of a small but real added risk.

Catalog record

CREATORCollaborative Group on Epidemiological Studies of Ovarian Cancer
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4427760

Browse the full library · About the Tower of Babel